undamentalytics Newsletter

National Health Investors Inc insider trading

Every open-market purchase and sale by National Health Investors Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
National Health Investors Inc insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following National Health Investors Inc’s insiders pay?

From January 5, 2010 to June 15, 2026, 13 insiders reported 57 open-market purchases and 47 sales not made under a pre-set plan in National Health Investors Inc. Twelve months after each purchase was reported, the shares were +12.2% against the S&P 500 on average (median +9.4%), over 55 purchases with a full year of prices; 66% beat the index. After sales, the shares moved −4.0% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 13, 2010 into $41,479 by November 2, 2026, +9.2% a year. It held shares 72% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $53,089 (+10.9% a year), and held throughout $89,354 (+14.6%).

$0$25.0k$50.0k$75.0k 201020122014201620182020202220242026 $89.4k$53.1k$41.5k
Copying National Health Investors Inc's insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by National Health Investors Inc's insiders from September 13, 2010, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 72% of the time.
National Health Investors Inc: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Mccabe Robert A Jr Director 15 +5.8% (14) 50% 9 −2.3% (9) June 15, 2026
Webb Robert T Director 8 +30.8% (8) 100% 7 +7.0% (7) December 1, 2021
Gaines Kristin Sallee Chief Credit Officer 2 +17.4% (2) 50% 9 −5.7% (9) December 14, 2018
Hutchens James Justin CEO and President 5 −2.1% (5) 60% 6 −5.6% (6) April 2, 2015
Mendelsohn D. Eric CEO and President 10 +26.7% (9) 100% 1 −41.0% (1) June 5, 2026
Hopkins Roger R Chief Accounting Officer 2 +15.2% (2) 50% 5 +8.6% (5) March 29, 2016
Adams Robert G Director 6 −20.2% (6) 17% 0 — December 15, 2022
Pascoe Kevin Carlton Chief Investment Officer 1 +35.0% (1) 100% 5 −24.4% (5) February 25, 2020
Jobe James R Director 4 +12.9% (4) 50% 1 −37.1% (1) August 31, 2023
Adams W Andrew Chief Executive Officer 2 +18.6% (2) 50% 2 +5.1% (2) March 25, 2020
Welch Ted H Director 0 — — 2 +7.2% (2) February 24, 2011
Spaid John L Exec. VP of Finance 1 +23.6% (1) 100% 0 — February 23, 2018
Swafford Charlotte A Director 1 +18.8% (1) 100% 0 — February 28, 2024

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded National Health Investors Inc

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of National Health Investors Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 7 buying crowds with six months of prices, it averaged +5.9% against the index. After 6 selling crowds, −0.4%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
June 30, 20262 buying−15.2%not yetnot yet
January 31, 20222 buying−3.0%+24.2%+15.9%
September 30, 20212 buying−2.6%+7.8%+27.8%
May 29, 20204 buying+1.0%+3.6%−13.2%
December 31, 20183 selling−9.6%−12.4%−17.6%
February 28, 20183 buying+14.7%+17.5%+22.0%
June 30, 20163 selling+4.0%−8.6%−7.0%
May 29, 20152 buying−7.8%−7.1%+9.9%
May 30, 20142 buying−0.2%+0.1%−0.4%
September 30, 20132 buying−8.9%−4.5%−13.8%
December 31, 20123 selling+7.3%−2.2%−27.7%
June 29, 20124 selling−4.0%+8.4%+4.5%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Latest 12 of 14. Total returns from the month end; past patterns are not a forecast.

← Back to National Health Investors Inc · Funds · Politicians